Expression and function of human hemokinin-1 in human and guinea pig airways

Respiratory Research

Volumn 11, Issue , 2010, Pages

  Grassin Delyle, Stanislas ^a   Naline, Emmanuel ^a   Buenestado, Amparo ^a   Risse, Paul André ^a,b   Sage, Edouard ^a   Advenier, Charles ^a   Devillier, Philippe ^a  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOKININ; HUMAN HEMOKININ 1; PROTEINASE; TACHYKININ; TACHYKININ RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG; HEMOKININ 1; HEMOKININ-1;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRONCHUS; CYTOKINE PRODUCTION; EXPLANT; FEMALE; GUINEA PIG; HUMAN; HUMAN TISSUE; LUNG ALVEOLUS MACROPHAGE; LUNG PARENCHYMA; MALE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR DOWN REGULATION; RECEPTOR GENE; TRACHEA; ANIMAL; BIOSYNTHESIS; BRONCHOSPASM; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; PHYSIOLOGY; SPECIES DIFFERENCE;

ANIMALS; BRONCHI; BRONCHOCONSTRICTION; FEMALE; GENE EXPRESSION REGULATION; GUINEA PIGS; HUMANS; MALE; SPECIES SPECIFICITY; TACHYKININS;

EID: 77957372872     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-11-139     Document Type: Article

References (66)

1. Kotani H, Hoshimaru M, Nawa H, Nakanishi S. Structure and gene organization of bovine neuromedin K precursor. Proc Natl Acad Sci USA 1986, 83(18):7074-7078. 10.1073/pnas.83.18.7074, 386655, 3462746.
2. Page NM, Woods RJ, Lowry PJ. A regulatory role for neurokinin B in placental physiology and pre-eclampsia. Regul Pept 2001, 98(3):97-104. 10.1016/S0167-0115(00)00239-1, 11231038.
3. Zhang Y, Lu L, Furlonger C, Wu GE, Paige CJ. Hemokinin is a hematopoietic-specific tachykinin that regulates B lymphopoiesis. Nat Immunol 2000, 1(5):392-397. 10.1038/80826, 11062498.
4. Kurtz MM, Wang R, Clements MK, Cascieri MA, Austin CP, Cunningham BR, Chicchi GG, Liu Q. Identification, localization and receptor characterization of novel mammalian substance P-like peptides. Gene 2002, 296(1-2):205-212. 10.1016/S0378-1119(02)00861-2, 12383518.
5. Page NM. Hemokinins and endokinins. Cell Mol Life Sci 2004, 61(13):1652-1663. 10.1007/s00018-004-4035-x, 15224188.
6. Page NM, Bell NJ, Gardiner SM, Manyonda IT, Brayley KJ, Strange PG, Lowry PJ. Characterization of the endokinins: human tachykinins with cardiovascular activity. Proc Natl Acad Sci USA 2003, 100(10):6245-6250. 10.1073/pnas.0931458100, 156357, 12716968.
7. Almeida TA, Rojo J, Nieto PM, Pinto FM, Hernandez M, Martin JD, Candenas ML. Tachykinins and tachykinin receptors: structure and activity relationships. Curr Med Chem 2004, 11(15):2045-2081.
8. Maggi CA. The mammalian tachykinin receptors. Gen Pharmacol 1995, 26(5):911-944.
9. Regoli D, Boudon A, Fauchere JL. Receptors and antagonists for substance P and related peptides. Pharmacol Rev 1994, 46(4):551-599.
10. Bellucci F, Carini F, Catalani C, Cucchi P, Lecci A, Meini S, Patacchini R, Quartara L, Ricci R, Tramontana M, et al. Pharmacological profile of the novel mammalian tachykinin, hemokinin 1. Br J Pharmacol 2002, 135(1):266-274. 10.1038/sj.bjp.0704443, 1573107, 11786503.
11. Morteau O, Lu B, Gerard C, Gerard NP. Hemokinin 1 is a full agonist at the substance P receptor. Nat Immunol 2001, 2(12):1088. 10.1038/ni1201-1088, 11725292.
12. Duffy RA, Hedrick JA, Randolph G, Morgan CA, Cohen-Williams ME, Vassileva G, Lachowicz JE, Laverty M, Maguire M, Shan LS, et al. Centrally administered hemokinin-1 (HK-1), a neurokinin NK1 receptor agonist, produces substance P-like behavioral effects in mice and gerbils. Neuropharmacology 2003, 45(2):242-250. 10.1016/S0028-3908(03)00150-3, 12842130.
13. Camarda V, Rizzi A, Calo G, Guerrini R, Salvadori S, Regoli D. Pharmacological profile of hemokinin 1: a novel member of the tachykinin family. Life Sci 2002, 71(4):363-370. 10.1016/S0024-3205(02)01682-X, 12044836.
14. Metwali A, Blum AM, Elliott DE, Setiawan T, Weinstock JV. Cutting edge: hemokinin has substance P-like function and expression in inflammation. J Immunol 2004, 172(11):6528-6532.
15. Zhang Y, Paige CJ. T-cell developmental blockage by tachykinin antagonists and the role of hemokinin 1 in T lymphopoiesis. Blood 2003, 102(6):2165-2172. 10.1182/blood-2002-11-3572, 12791665.
16. Weinstock JV. The role of substance P, hemokinin and their receptor in governing mucosal inflammation and granulomatous responses. Front Biosci 2004, 9:1936-1943. 10.2741/1375, 14977599.
17. Long Y, Fu CY, Tian XZ, Chen J, Han M, Wang R. Mechanisms of relaxing response induced by rat/mouse hemokinin-1 in porcine coronary arteries: roles of potassium ion and nitric oxide. Eur J Pharmacol 2007, 569(1-2):119-125. 10.1016/j.ejphar.2007.04.049, 17560993.
18. Patak E, Pennefather JN, Gozali M, Candenas L, Kerr K, Exintaris B, Ziccone S, Potteck H, Chetty N, Page NM, et al. Functional characterisation of hemokinin-1 in mouse uterus. Eur J Pharmacol 2008, 601(1-3):148-53. 10.1016/j.ejphar.2008.10.036, 18977217.
19. Pennefather JN, Patak E, Ziccone S, Lilley A, Pinto FM, Page NM, Story ME, Grover S, Candenas ML. Regulation of the Stimulant Actions of Neurokinin A and Human Hemokinin-1 on Human Uterus: a Comparison with Histamine. Biol Reprod 2006, 75(3):334-41. 10.1095/biolreprod.106.051508, 16707771.
20. Kong ZQ, Yang WL, Tao Y, Shi XM, Fu CY, Zhao RF, Wang R. Effects of rat/mouse hemokinin-1, human hemokinin-1 and human hemokinin-1(4-11), mammalian tachykinin peptides, on rate and perfusion pressure in the isolated guinea pig heart. Neuropeptides 2010, 44(5):437-44. 10.1016/j.npep.2010.04.006, 20471676.
21. Naline E, Devillier P, Drapeau G, Toty L, Bakdach H, Regoli D, Advenier C. Characterization of neurokinin effects and receptor selectivity in human isolated bronchi. Am Rev Respir Dis 1989, 140(3):679-686.
22. Naline E, Molimard M, Regoli D, Emonds-Alt X, Bellamy JF, Advenier C. Evidence for functional tachykinin NK1 receptors on human isolated small bronchi. Am J Physiol 1996, 271(5 Pt 1):L763-767.
23. Advenier C, Naline E, Drapeau G, Regoli D. Relative potencies of neurokinins in guinea pig trachea and human bronchus. Eur J Pharmacol 1987, 139(2):133-137. 10.1016/0014-2999(87)90244-5, 2888665.
24. Lundberg JM, Martling CR, Saria A. Substance P and capsaicin-induced contraction of human bronchi. Acta Physiol Scand 1983, 119(1):49-53. 10.1111/j.1748-1716.1983.tb07304.x, 6196939.
25. Frossard N, Barnes J. Effect of tachykinins in small human airways. Neuropeptides 1991, 19(3):157-161. 10.1016/0143-4179(91)90113-W, 1716742.
26. Girard V, Feletou M, Advenier C, Canet E. Effects of tachykinins and capsaicin on the mechanical and electrical activity of the guinea-pig isolated trachea. Br J Pharmacol 1997, 122(5):841-848. 10.1038/sj.bjp.0701459, 1565015, 9384499.
27. Groneberg DA, Quarcoo D, Frossard N, Fischer A. Neurogenic mechanisms in bronchial inflammatory diseases. Allergy 2004, 59(11):1139-1152. 10.1111/j.1398-9995.2004.00665.x, 15461593.
28. Heaney LG, Cross LJ, Stanford CF, Ennis M. Substance P induces histamine release from human pulmonary mast cells. Clin Exp Allergy 1995, 25(2):179-186. 10.1111/j.1365-2222.1995.tb01024.x, 7538443.
29. Wiedermann FJ, Kahler CM, Reinisch N, Wiedermann CJ. Induction of normal human eosinophil migration in vitro by substance P. Acta Haematol 1993, 89(4):213-215. 10.1159/000204527, 7692691.
30. Carolan EJ, Casale TB. Effects of neuropeptides on neutrophil migration through noncellular and endothelial barriers. J Allergy Clin Immunol 1993, 92(4):589-598. 10.1016/0091-6749(93)90083-R, 7691915.
31. Iwamoto I, Nakagawa N, Yamazaki H, Kimura A, Tomioka H, Yoshida S. Mechanism for substance P-induced activation of human neutrophils and eosinophils. Regul Pept 1993, 46(1-2):228-230. 10.1016/0167-0115(93)90042-7, 7692498.
32. Schratzberger P, Reinisch N, Prodinger WM, Kahler CM, Sitte BA, Bellmann R, Fischer-Colbrie R, Winkler H, Wiedermann CJ. Differential chemotactic activities of sensory neuropeptides for human peripheral blood mononuclear cells. J Immunol 1997, 158(8):3895-3901.
33. Boichot E, Lagente V, Paubert-Braquet M, Frossard N. Inhaled substance P induces activation of alveolar macrophages and increases airway responses in the guinea-pig. Neuropeptides 1993, 25(5):307-313. 10.1016/0143-4179(93)90048-F, 7509466.
34. Nelson DA, Bost KL. Non-neuronal mammalian tachykinin expression. Front Biosci 2004, 9:2166-2176. 10.2741/1372, 15353278.
35. Pennefather JN, Lecci A, Candenas ML, Patak E, Pinto FM, Maggi CA. Tachykinins and tachykinin receptors: a growing family. Life Sci 2004, 74(12):1445-1463. 10.1016/j.lfs.2003.09.039, 14729395.
36. Maggi CA. The effects of tachykinins on inflammatory and immune cells. Regul Pept 1997, 70(2-3):75-90. 10.1016/S0167-0115(97)00029-3, 9272619.
37. Ben-Jebria A, Marthan R, Rossetti M, Savineau JP. Effect of passive sensitization on the mechanical activity of human isolated bronchial smooth muscle induced by substance P, neurokinin A and VIP. Br J Pharmacol 1993, 109(1):131-136. 2175608, 7684296.
38. Yoshioka D, Takebuchi F, Nishimori T, Naono R, Ikeda T, Nakayama T. Intrathecal administration of the common carboxyl-terminal decapeptide in endokinin A and endokinin B evokes scratching behavior and thermal hyperalgesia in the rat. Neurosci Lett 2006, 410(3):193-197. 10.1016/j.neulet.2006.09.024, 17101218.
39. Ravina CG, Seda M, Pinto FM, Orea A, Fernandez-Sanchez M, Pintado CO, Candenas ML. A role for tachykinins in the regulation of human sperm motility. Hum Reprod 2007, 22(6):1617-1625. 10.1093/humrep/dem069, 17437961.
40. Devillier P, Advenier C, Drapeau G, Marsac J, Regoli D. Comparison of the effects of epithelium removal and of an enkephalinase inhibitor on the neurokinin-induced contractions of guinea-pig isolated trachea. Br J Pharmacol 1988, 94(3):675-684. 1854024, 2460177.
41. Emonds-Alt X, Bichon D, Ducoux JP, Heaulme M, Miloux B, Poncelet M, Proietto V, Van Broeck D, Vilain P, Neliat G, et al. SR 142801, the first potent non-peptide antagonist of the tachykinin NK3 receptor. Life Sci 1995, 56(1):PL27-32. 10.1016/0024-3205(94)00413-M, 7830490.
42. Emonds-Alt X, Doutremepuich JD, Heaulme M, Neliat G, Santucci V, Steinberg R, Vilain P, Bichon D, Ducoux JP, Proietto V, et al. In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist. Eur J Pharmacol 1993, 250(3):403-413. 10.1016/0014-2999(93)90027-F, 7509286.
43. Emonds-Alt X, Vilain P, Goulaouic P, Proietto V, Van Broeck D, Advenier C, Naline E, Neliat G, Le Fur G, Breliere JC. A potent and selective non-peptide antagonist of the neurokinin A (NK2) receptor. Life Sci 1992, 50(15):PL101-106. 10.1016/0024-3205(92)90352-P, 1313515.
44. Berger A, Tran AH, Paige CJ. Co-regulated decrease of Neurokinin-1 receptor and Hemokinin-1 gene expression in monocytes and macrophages after activation with pro-inflammatory cytokines. J Neuroimmunol 2007, 187(1-2):83-93. 10.1016/j.jneuroim.2007.04.019, 17537522.
45. Mitsuta K, Shimoda T, Fukushima C, Obase Y, Ayabe H, Matsuse H, Kohno S. Preoperative steroid therapy inhibits cytokine production in the lung parenchyma in asthmatic patients. Chest 2001, 120(4):1175-1183. 10.1378/chest.120.4.1175, 11591557.
46. Buenestado A, Grassin Delyle S, Arnould I, Besnard F, Naline E, Blouquit-Laye S, Chapelier A, Bellamy JF, Devillier P. The role of adenosine receptors in regulating production of tumour necrosis factor-alpha and chemokines by human lung macrophages. Br J Pharmacol 2010, 159(6):1304-1311. 10.1111/j.1476-5381.2009.00614.x, 20136829.
47. Klassert TE, Pinto F, Hernandez M, Candenas ML, Hernandez MC, Abreu J, Almeida TA. Differential expression of neurokinin B and hemokinin-1 in human immune cells. J Neuroimmunol 2008, 196(1-2):27-34. 10.1016/j.jneuroim.2008.02.010, 18400309.
48. Pinto FM, Almeida TA, Hernandez M, Devillier P, Advenier C, Candenas ML. mRNA expression of tachykinins and tachykinin receptors in different human tissues. Eur J Pharmacol 2004, 494(2-3):233-239. 10.1016/j.ejphar.2004.05.016, 15212980.
49. Mapp CE, Miotto D, Braccioni F, Saetta M, Turato G, Maestrelli P, Krause JE, Karpitskiy V, Boyd N, Geppetti P, et al. The distribution of neurokinin-1 and neurokinin-2 receptors in human central airways. Am J Respir Crit Care Med 2000, 161(1):207-215.
50. Baraniuk JN, Ohkubo K, Kwon OJ, Mak J, Ali M, Davies R, Twort C, Kaliner M, Letarte M, Barnes PJ. Localization of neutral endopeptidase (NEP) mRNA in human bronchi. Eur Respir J 1995, 8(9):1458-1464.
51. Culman J, Tschope C, Jost N, Itoi K, Unger T. Substance P and neurokinin A induced desensitization to cardiovascular and behavioral effects: evidence for the involvement of different tachykinin receptors. Brain Res 1993, 625(1):75-83. 10.1016/0006-8993(93)90139-E, 7694777.
52. Nakanishi S. Mammalian tachykinin receptors. Annu Rev Neurosci 1991, 14:123-136. 10.1146/annurev.ne.14.030191.001011, 1851606.
53. Berger A, Paige CJ. Hemokinin-1 has Substance P-like function in U-251 MG astrocytoma cells: a pharmacological and functional study. J Neuroimmunol 2005, 164(1-2):48-56. 10.1016/j.jneuroim.2005.03.016, 15913794.
54. Naono R, Yoshioka D, Ikeda T, Nakayama T, Nishimori T. The common carboxyl-terminal region of novel tachykinin peptides contributes to induce desensitization in scratching behavior of rats. Brain Res Bull 2007, 71(5):461-465. 10.1016/j.brainresbull.2006.10.002, 17259014.
55. Hokfelt T, Pernow B, Wahren J. Substance P: a pioneer amongst neuropeptides. J Intern Med 2001, 249(1):27-40. 10.1046/j.0954-6820.2000.00773.x, 11168782.
56. Kong ZQ, Fu CY, Chen Q, Wang R. Cardiovascular responses to intravenous administration of human hemokinin-1 and its truncated form hemokinin-1(4-11) in anesthetized rats. Eur J Pharmacol 2008, 590(1-3):310-316. 10.1016/j.ejphar.2008.05.049, 18582457.
57. Bardelli C, Gunella G, Varsaldi F, Balbo P, Del Boca E, Bernardone IS, Amoruso A, Brunelleschi S. Expression of functional NK1 receptors in human alveolar macrophages: superoxide anion production, cytokine release and involvement of NF-kappaB pathway. Br J Pharmacol 2005, 145(3):385-396. 10.1038/sj.bjp.0706198, 1576149, 15778738.
58. Lieb K, Fiebich BL, Busse-Grawitz M, Hull M, Berger M, Bauer J. Effects of substance P and selected other neuropeptides on the synthesis of interleukin-1 beta and interleukin-6 in human monocytes: a re-examination. J Neuroimmunol 1996, 67(2):77-81.
59. Brunelleschi S, Guidotto S, Viano I, Fantozzi R, Pozzi E, Ghio P, Albera C. Tachykinin activation of human alveolar macrophages in tobacco smoke and sarcoidosis: a phenotypical and functional study. Neuropeptides 1996, 30(5):456-464. 10.1016/S0143-4179(96)90010-4, 8923508.
60. Pujol JL, Bousquet J, Grenier J, Michel F, Godard P, Chanez P, de Vos C, Crastes de Paulet A, Michel FB. Substance P activation of bronchoalveolar macrophages from asthmatic patients and normal subjects. Clin Exp Allergy 1989, 19(6):625-628. 10.1111/j.1365-2222.1989.tb02757.x, 2480840.
61. Derocq JM, Segui M, Blazy C, Emonds-Alt X, Le Fur G, Brelire JC, Casellas P. Effect of substance P on cytokine production by human astrocytic cells and blood mononuclear cells: characterization of novel tachykinin receptor antagonists. FEBS Lett 1996, 399(3):321-325. 10.1016/S0014-5793(96)01346-4, 8985172.
62. Lundberg JM, Hokfelt T, Martling CR, Saria A, Cuello C. Substance P-immunoreactive sensory nerves in the lower respiratory tract of various mammals including man. Cell Tissue Res 1984, 235(2):251-261. 10.1007/BF00217848, 6200231.
63. Ollerenshaw SL, Jarvis D, Sullivan CE, Woolcock AJ. Substance P immunoreactive nerves in airways from asthmatics and nonasthmatics. Eur Respir J 1991, 4(6):673-682.
64. Nieber K, Baumgarten CR, Rathsack R, Furkert J, Oehme P, Kunkel G. Substance P and beta-endorphin-like immunoreactivity in lavage fluids of subjects with and without allergic asthma. J Allergy Clin Immunol 1992, 90(4 Pt 1):646-652. 10.1016/0091-6749(92)90138-R, 1383307.
65. Tomaki M, Ichinose M, Miura M, Hirayama Y, Yamauchi H, Nakajima N, Shirato K. Elevated substance P content in induced sputum from patients with asthma and patients with chronic bronchitis. Am J Respir Crit Care Med 1995, 151(3 Pt 1):613-617.
66. Cardell LO, Uddman R, Edvinsson L. Low plasma concentrations of VIP and elevated levels of other neuropeptides during exacerbations of asthma. Eur Respir J 1994, 7(12):2169-2173. 10.1183/09031936.94.07122169, 7713199.